Cargando…
MicroRNA‑155 modulation of CD8(+) T‑cell activity personalizes response to disease‑modifying therapies of patients with relapsing‑remitting multiple sclerosis
Multiple sclerosis (MS) is a chronic autoimmune disease where activated immune cells can attack oligodendrocytes causing damage to the myelin sheath. Several molecular mechanisms are responsible for the auto-activation of immune cells such as RNA interference (RNAi) through microRNAs (miRNAs or miRs...
Autores principales: | Elkhodiry, Aya A., Zamzam, Dina A., El Tayebi, Hend M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080195/ https://www.ncbi.nlm.nih.gov/pubmed/37032715 http://dx.doi.org/10.3892/mi.2023.80 |
Ejemplares similares
-
Scavenging the hidden impacts of non-coding RNAs in multiple sclerosis
por: Elkhodiry, Aya A., et al.
Publicado: (2021) -
Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: González-Andrade, Fabricio, et al.
Publicado: (2010) -
Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis
por: Groen, Kira, et al.
Publicado: (2018) -
Glatiramer Acetate Treatment Normalizes Deregulated microRNA Expression in Relapsing Remitting Multiple Sclerosis
por: Waschbisch, Anne, et al.
Publicado: (2011) -
Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis
por: Stühler, E., et al.
Publicado: (2020)